DGAP-News: KTG Energie AG: Substantial increase in sales

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 31, 2014 at 4:30 AM

DGAP-News: KTG Energie AG: Substantial increase in sales and revenue base

DGAP-News: KTG Energie AG / Key word(s): Miscellaneous KTG Energie AG: Substantial increase in sales and revenue base 31.07.2014 / 10:19 --------------------------------------------------------------------- KTG Energie AG: Substantial increase in sales and revenue base - Sales base reaches EUR80 million - EBITDA base more than EUR22 million - Installed system power grows to 53 MW - Target values surpassed at July 31 - EUR50 million bond fully placed Hamburg, July 31, 2014 - KTG Energie AG (ISIN: DE000A0HNG53) has surpassed its expansion goals for the current fiscal year, which ends on October 31. KTG Energie today put into operation additional new systems with a capacity of 10 MW - just in time before the amendment to the Renewable Energy Act (EEG) which will come into effect tomorrow. The company is thus able to benefit from the favorable conditions of EEG 2012 for all of the newly installed capacity. KTG Energie now has biogas plants with a total output of 53 MW at its disposal. From fiscal year 2014/2015, this corresponds to a sales base of EUR80 million secured in the long-term, and a long-lasting, secure revenue basis of over EUR22 million. KTG Energie has thus considerably surpassed its own goal of connecting systems with an output of 50 MW to the grid by July 31 and thus of securing a sales base of EUR75 million and a EBITDA base of over EUR20 million. "We are proud of the achievement of our employees, who have succeeded in achieving an even higher sales and revenue base than forecast for our shareholders", says Dr. Thomas Berger, CEO of KTG Energie AG. For the current fiscal year, the Executive Board is anticipating sales of over EUR65 million, EBITDA of between EUR19.5 and EUR20.5 million and EBIT of between EUR12 and EUR12.5 million. "It was a three-point landing by our team which we prepared and planned meticulously. In the past six months, the focus was on both on-time expansion and system operation", says Christian Heck, COO of KTG Energie AG. EUR50 million bond fully placed - sights set on acquisitions In addition, KTG Energie AG has completely placed the bond (A1ML25 / DE000A1ML257) in the meantime and fully utilized the volume of EUR50 million. The bond has a runtime up to 09/28/2018, and the annual coupon amounts to 7.250%. The approximately EUR7 million that KTG Energie has received from the placement of the bond will be invested in the project funding of ongoing capacity expansion. In future, KTG Energie wants to drive growth through favorable acquisition opportunities, additional optimization potential of existing systems and new opportunities in the market for mobile heat transfer, as well as in the construction of biogas systems that use agricultural and biological waste material. About KTG Energie AG KTG Energie AG, based in Hamburg, is specialized in the production of renewable energies from renewable raw materials. To this end, the company has been operating biogas plants in Germany since 2006 and covers the entire value added chain from the planning and construction to the operation of the systems. Sales quantities are guaranteed through the Renewable Energy Act (EEG) for a period of 20 years at fixed conditions. Today, over a quarter of a million people are already supplied with clean, environmentally-friendly energy. As a subsidiary of the agricultural company KTG Agrar AG, the supply of renewable raw materials - particularly catch crops, grass and straw - is guaranteed in the long term. KTG Energie currently employs around 69 staff. In the short fiscal year 2013, the company more than doubled sales volume to EUR50.9 million, in comparison with the first ten months of the previous year (January through October 2012: around EUR23 million). The operative result (EBITDA) improved by 97% to EUR13.2 million (January through October 2012: EUR6.7 million), while EBIT increased to EUR8 million. The individual company KTG Energie AG achieved a profit of over EUR3 million, of which it distributed almost 80% as a dividend to shareholders (EUR0.40 per share). The company has been listed on the Frankfurt Stock Exchange since 2012. Contact Investor Relations / Press Tobias M. Weitzel BSK Becker+Schreiner Kommunikation GmbH Phone: +49 2154-8122 16 E-mail: weitzel@kommunikation-bsk.de --------------------------------------------------------------------- 31.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: KTG Energie AG Ferdinandstr. 12 20095 Hamburg Germany Phone: +49 40 76755372 Fax: +49 40 76755374 E-mail: info@ktg-energie.de Internet: www.ktg-energie.de ISIN: DE000A0HNG53, DE000A1ML257, WKN: A0HNG5, A1ML25 Listed: Freiverkehr in Berlin, DÃ¼sseldorf, MÃ¼nchen, Stuttgart; Frankfurt in Open Market (Entry Standard) End of News DGAP News-Service --------------------------------------------------------------------- 280175 31.07.2014

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...